Back

Impact of sglt2 inhibitors on cardiovascular outcomes in patients with acute myocardial infarction

3 April 2025 (08:00 - 19:00)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award - Secondary Prevention and Rehabilitation Secondary Prevention EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Ramzi Ibrahim

Mayo Clinic Hospital, Phoenix (United States of America)

3 More presentations in this session

Presentation thumbnail
Participation in a comprehensive cardiac rehabilitation program improves mid- and long-term prognosis in survivors of acute coronary syndrome
Doctor C. Sari (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Prognostic value of coronary angiography-derived index of microcirculatory resistance in mild chronic kidney disease patients with chronic coronary syndrome
Mr C. Lui (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Association between comorbidities and the effects of exercise training among patients with heart failure with preserved ejection fraction
Doctor S. Mueller Stegner (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award - Secondary Prevention and Rehabilitation

The Event

Event poster

ESC Preventive Cardiology 2025

3 April - 5 April 2025
You may be interested in
thumbnail
Congress Presentation
What value do SGLT2 inhibitors offer to patients hospitalised for heart failure?
thumbnail
Congress Presentation
Beyond heart failure: impact of sodium-glucose co-transporter-2 inhibitors after acute coronary syndrome
thumbnail
Webinar
Clinical trials and highlights from ACC 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources